A Minnesota vascular access medical technology company announced that the Food and Drug Administration has cleared 28 sizes of a angioplasty balloon catheter that does not need viscous contrast media to be detected by physicians under an X-Ray.
The Vector Percutaneous Transluminal Angioplasty balloon catheter is made by r4 Vascular Inc. and contains “radiopaque stripes” such that a fluoroscopy does not need to be conducted to see it under an X-Ray. Instead physicians may use “low-viscosity saline which reduces inflation/deflation time up to 50% and may reduce x-ray exposure to the patient and clinicians,” the company said in a news release.
The company also develops products based on biomimetic coating technologies, imaging technologies and fluid modeling and analysis
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.